To investigate the impact of the daily consumption of a mealworm- and whey protein supplement on muscle damage upon physical exercise in vital active elderly.
ID
Source
Brief title
Condition
- Muscle disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary outcome is the muscle damage biomarkers Creatine Kinase in blood.
Secondary outcome
Body composition, muscle strength, blood lipids and inflammatory markers will
be measured as secondary study parameters. Via questionnaires the intake
compliance, consumer satisfaction, muscle soreness, general physical activity-
and food consumption patterns will be assessed.
Background summary
Elderly are confronted with a gradual loss of skeletal muscle mass, strength
and function as a consequence of aging (sarcopenia). Moreover, older adults
exhibit higher levels of muscle damage upon a physical exercise bout compared
to younger adults. Physical activities result in micro injuries to contractile
proteins, so-called muscle damage, as demonstrated by elevated muscle soreness
and an increase in plasma creatine kinase (CK). The intake of dietary proteins
may augment muscle repair through accelerating muscle protein turnover, which
is of great relevance elderly. Protein from insects has the potential of being
an eco-friendly and high-quality solution to meet future protein demands.
Previous studies in humans have shown that insect protein is equivalent in
terms of nutritional value compared to milk-derived protein. Moreover, the
ingestion of mealworm protein resulted in a substantial increase in
postprandial blood amino acid levels. Muscle protein synthesis rates, both at
rest and during recovery from exercise, were comparable upon the consumption of
a mealworm- or milk-derived protein supplement. Until now, human studies using
mealworm have been conducted in small groups of young participants and only the
effects upon acute exposure has been studied. Therefore, the current study was
designed to assess the effects of mealworm supplementation for three
consecutive months in older vital individuals.
Study objective
To investigate the impact of the daily consumption of a mealworm- and whey
protein supplement on muscle damage upon physical exercise in vital active
elderly.
Study design
Double-blind randomized placebo-controlled trial. The effects of daily
supplementation for 3 subsequent months, of 1) mealworm, 2) milk-derived
protein, or 3) an iso-caloric placebo, on muscle damage upon physical exercise
will be measured. Muscle damage will be induced by repeated bouts of prolonged
walking exercise (30-50 km per day) on 4 consecutive days. Since this study
will be the first to provide long-term mealworm protein supplementation, we
will also repeatedly measure body composition, muscle strength, blood lipids
and inflammatory markers to obtain valuable insights into other health effects
of mealworm protein.
Intervention
Subjects will be randomly assigned to one of the three groups. Daily
supplementation will be consumed at two doses/day (15 gram/dose), during
breakfast and after an exercise bout (or on days without exercise, during
lunch). Upon 3 months of supplement consumption, subjects will participate in
the Nijmegen Four Days Marches and they will walk 30-50 km on a self-selected
pace for four consecutive days. During the Nijmegen Four Days Marches the
protein/placebo supplement will also be consumed. Before, during and after the
protein supplementation and during the Nijmegen Four Days Marches event,
repeated blood sampling will be performed as well as the measurement of body
composition, muscle strength and the request to complete online questionnaires.
Study burden and risks
The risks involved in participating in this research are negligible. The
protein supplements provided are commercially available products with no
reported adverse effects. Protein and placebo supplements will be produced
according to the HACCP/ISO22000 regulations in certified facilities and using
approved ingredients. Most study procedures do not involve any risks for the
subjects. Measurements with a limited burden are blood sampling which is
associated with a 5% risk of developing a haemorrhage, but will fully disappear
within 2 weeks and is not associated with any (functional) limitations. Based
on previous studies, the two protein supplemented groups might benefit from
improved physical performance and reduced muscle soreness during and after the
Nijmegen Four Days Marches. All subjects will receive a summary of the obtained
study results after completion of the study.
Philips van Leijdenlaan 15
Nijmegen 6525 EX
NL
Philips van Leijdenlaan 15
Nijmegen 6525 EX
NL
Listed location countries
Age
Inclusion criteria
- 60 years of older
- Registered for the Nijmegen Four Days Marches 2022
- Able to understand and perform the study procedures
Exclusion criteria
- Type I or Type II diabetes
- Allergic or sensitive for milk proteins, or lactose intolerant
- Allergic or sensitive for shell and shellfish, like shrimp
- BMI >30kg/m2
- Diagnosed COPD
- Currently treated for cancer
- Diagnosed renal insufficiency
- Diagnosed intestinal diseases influencing the uptake of protein (i.e. active
inflammatory bowel disease, Crohn*s disease)
- Consumption of other freely available protein supplements on their own during
the total study period of about 4 months
- Use of statins
- Involved in a heavy resistance type exercise program
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL79716.091.21 |
NTR-new | NL9862 |